PROCTER & GAMBLE HEALTH | SANJIVANI PA | PROCTER & GAMBLE HEALTH/ SANJIVANI PA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 38.5 | 89.8% | View Chart |
P/BV | x | 10.6 | - | - | View Chart |
Dividend Yield | % | 2.0 | 0.0 | - |
PROCTER & GAMBLE HEALTH SANJIVANI PA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
SANJIVANI PA Mar-23 |
PROCTER & GAMBLE HEALTH/ SANJIVANI PA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 68 | 7,890.6% | |
Low | Rs | 3,883 | 25 | 15,657.3% | |
Sales per share (Unadj.) | Rs | 740.7 | 35.5 | 2,087.0% | |
Earnings per share (Unadj.) | Rs | 138.2 | 4.5 | 3,063.7% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 5.4 | 2,873.9% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0 | - | |
Avg Dividend yield | % | 2.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 447.6 | -3.1 | -14,575.7% | |
Shares outstanding (eoy) | m | 16.60 | 10.00 | 166.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 1.3 | 477.6% | |
Avg P/E ratio | x | 33.5 | 10.3 | 325.3% | |
P/CF ratio (eoy) | x | 29.8 | 8.6 | 346.8% | |
Price / Book Value ratio | x | 10.3 | -15.1 | -68.4% | |
Dividend payout | % | 68.7 | 0 | - | |
Avg Mkt Cap | Rs m | 76,761 | 464 | 16,546.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 29 | 7,092.2% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 355 | 3,464.5% | |
Other income | Rs m | 184 | 9 | 1,954.3% | |
Total revenues | Rs m | 12,480 | 364 | 3,425.6% | |
Gross profit | Rs m | 3,247 | 53 | 6,184.4% | |
Depreciation | Rs m | 281 | 9 | 3,164.4% | |
Interest | Rs m | 8 | 4 | 214.5% | |
Profit before tax | Rs m | 3,142 | 49 | 6,355.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 4 | 19,568.1% | |
Profit after tax | Rs m | 2,295 | 45 | 5,085.8% | |
Gross profit margin | % | 26.4 | 14.8 | 178.5% | |
Effective tax rate | % | 27.0 | 8.8 | 308.0% | |
Net profit margin | % | 18.7 | 12.7 | 146.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 83 | 14,169.9% | |
Current liabilities | Rs m | 6,791 | 227 | 2,997.7% | |
Net working cap to sales | % | 40.0 | -40.5 | -98.7% | |
Current ratio | x | 1.7 | 0.4 | 472.7% | |
Inventory Days | Days | 263 | 53 | 494.3% | |
Debtors Days | Days | 343 | 20,452,423 | 0.0% | |
Net fixed assets | Rs m | 10,617 | 127 | 8,331.6% | |
Share capital | Rs m | 166 | 100 | 166.0% | |
"Free" reserves | Rs m | 7,265 | -131 | -5,558.6% | |
Net worth | Rs m | 7,431 | -31 | -24,195.7% | |
Long term debt | Rs m | 0 | 8 | 0.0% | |
Total assets | Rs m | 22,330 | 210 | 10,629.1% | |
Interest coverage | x | 409.1 | 14.8 | 2,769.2% | |
Debt to equity ratio | x | 0 | -0.2 | -0.0% | |
Sales to assets ratio | x | 0.6 | 1.7 | 32.6% | |
Return on assets | % | 10.3 | 23.2 | 44.5% | |
Return on equity | % | 30.9 | -146.9 | -21.0% | |
Return on capital | % | 42.4 | -229.4 | -18.5% | |
Exports to sales | % | 0 | 63.8 | 0.0% | |
Imports to sales | % | 13.1 | 3.5 | 370.6% | |
Exports (fob) | Rs m | NA | 227 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 13 | 12,843.2% | |
Fx inflow | Rs m | 1,465 | 227 | 646.8% | |
Fx outflow | Rs m | 1,605 | 13 | 12,843.2% | |
Net fx | Rs m | -140 | 214 | -65.5% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 47 | 5,038.4% | |
From Investments | Rs m | -215 | -10 | 2,169.5% | |
From Financial Activity | Rs m | -985 | -37 | 2,639.9% | |
Net Cashflow | Rs m | 1,160 | 0 | -313,594.6% |
Indian Promoters | % | 0.0 | 27.7 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 9.7 | 205.9% | |
FIIs | % | 6.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 72.3 | 66.6% | |
Shareholders | 56,778 | 4,911 | 1,156.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | SANJIVANI PA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | 5.27% | 0.45% |
1-Month | -1.15% | 34.10% | 2.55% |
1-Year | 0.73% | 265.88% | 56.14% |
3-Year CAGR | -8.76% | 157.50% | 15.22% |
5-Year CAGR | 4.97% | 124.68% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the SANJIVANI PA share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of SANJIVANI PA the stake stands at 27.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of SANJIVANI PA.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
SANJIVANI PA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of SANJIVANI PA.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.